CGNX vs BMI
Head-to-Head Stock Analysis & Investment Rating
Last Updated: Aug 01, 2026
CGNX
BMI
Investment Advisor Scores
BMI
AI Analyst Insights
Detailed Metrics Comparison
| Metric | CGNX | BMI | Winner |
|---|---|---|---|
|
Valuation
Lower P/E and PEG ratios suggest a stock may be undervalued relative to earnings and growth. Value investors prefer lower multiples. |
|||
| Forward P/E | 33.8983 | 28.7356 | BMI |
| PEG Ratio | 2.7121 | 3.3589 | CGNX |
|
Growth
Higher revenue and earnings growth rates indicate a company is expanding faster. Strong growth often justifies premium valuations. |
|||
| Revenue Growth | 24.3% | -6.6% | CGNX |
| Earnings Growth | 122.3% | -12.8% | CGNX |
|
Quality & Profitability
Higher Tradestie Score and profit margins reveal how efficiently a company operates. Strong profitability indicates competitive advantages. |
|||
| Tradestie Score | 60.7/100 | 45.7/100 | CGNX |
| Profit Margin | 13.6% | 14.3% | BMI |
|
Risk Profile
Lower Beta and Implied Volatility values indicate reduced market risk. Conservative investors favor stocks with less price volatility. |
|||
| Beta | 1.00 | 1.00 | Tie |
|
Sentiment
AI Recommendation reflects overall analyst and proprietary sentiment. Stronger recommendations signal higher conviction. |
|||
| AI Recommendation | BUY | HOLD | CGNX |
Relative Price Performance (Last 90 Days)
Current Technical Phase
CGNX
MarkupPrice above SMA50, rising 50-day trend (2.4% over 20 days), RSI 54
BMI
NeutralMixed signals - no dominant trend phase, RSI 48
Fundamentals Snapshot
| Metric | CGNX | BMI |
|---|---|---|
| Market Cap | — | — |
| Forward P/E | 36.6 | 27.2 |
| Trailing P/E | 73.7 | 31.3 |
| Revenue (TTM) | — | — |
| Revenue Growth | 0.2% | -0.1% |
| Gross Margin | 0.7% | 0.4% |
| Operating Margin | 0.2% | 0.2% |
| EPS | 0.85 | 4.17 |
| Dividend Yield | 0.01% | 0.01% |